5-iodo-1-pentanol | CAS:67133-88-4

We serve 5-iodo-1-pentanol CAS:67133-88-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
5-iodo-1-pentanol

Chemical Name:5-iodo-1-pentanol
CAS.NO:67133-88-4
Synonyms:5-iodo-1-pentanol
5-iodopentan-1-ol
5-iodo-pentan-1-ol
5-iodopentane-1-ol
5-iodopentanol
Molecular Formula:C5H11IO
Molecular Weight:214.04500
 
Specification:
Appearance:Colorless to yellow liquid
Assay:≥98.0%
Moisture:≤0.3%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like 5-iodo-1-pentanol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-iodopentanol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-iodopentanol Use and application,5-iodopentane-1-ol technical grade,usp/ep/jp grade.


Related News: Beta Bionics is pursuing regulatory approval of its insulin-only bionic pancreas, followed by its dual-hormone system, which will also administer a glucagon analog in order to raise blood-sugar levels without the need to consume carbohydrates. Beta Bionics operates in Massachusetts and California.4-Chlorobenzyl Chloride manufacturer Beta Bionics is pursuing regulatory approval of its insulin-only bionic pancreas, followed by its dual-hormone system, which will also administer a glucagon analog in order to raise blood-sugar levels without the need to consume carbohydrates. Beta Bionics operates in Massachusetts and California.4-(Difluoromethoxy)benzenesulfonamide supplier The man recently traveled to Wuhan, China, and sought medical care soon after his return to Massachusetts.(S)-(+)-2,2-Dimethylcyclopropane Carboxamide vendor Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders.Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders.